Salīdzināt metodes

	Alcheimera slimības novērtēšanas skala-kognitīvā	Frontal Assessment Battery
Nozare	Neiropsiholoģija	Neiropsiholoģija
Saime	Process / pipeline	Process / pipeline
Izcelsmes gads	1984	2000
Autors	William Rosen	Bruno Dubois
Tips	Clinician-administered cognitive scale for Alzheimer's disease	Clinician-administered neuropsychological battery for frontal lobe function
Pirmavots	Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141(11), 1356-1364.	Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621-1626.
Citi nosaukumi	ADAS-Cog, ADAS-Cog14, ADAS-Cog13	FAB, Frontal Battery
Saistītās	5	5
Kopsavilkums	The Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) is a clinician-administered cognitive assessment instrument designed specifically to measure cognitive decline in Alzheimer's disease. Developed by Rosen, Mohs, and Davis in 1984 and published in the American Journal of Psychiatry, the ADAS-Cog has become the gold standard outcome measure in pharmaceutical trials of antidementia drugs. It is sensitive to disease progression and capable of detecting cognitive change over periods as brief as 6–12 months.	The Frontal Assessment Battery (FAB) is a brief, clinician-administered neuropsychological battery designed to assess frontal lobe function and executive abilities at the bedside. Developed by Dubois and colleagues at the Salpêtrière Hospital in Paris in 2000, the FAB consists of six subtests measuring conceptualization, mental flexibility, motor planning, inhibitory control, and verbal fluency. The FAB is particularly sensitive to frontotemporal dementia, Parkinson's disease with cognitive decline, and other conditions affecting prefrontal function.